Abstract
As part of the first randomized, sham-timulation controlled trial on deep brain stimulation (DBS) in primary segmental or generalized dystonia, health-related quality of life (HRQoL) was assessed by SF-36. After the 3-month sham-controlled phase, significant HRQoL improvement occurred only in the active-stimulation group. The open-label extension phase resulted in a significant improvement in all SF-36 domains following 6 months of neurostimulation. These results demonstrate a favorable impact of DBS on HRQoL in primary dystonia.
Originalsprache | Englisch |
---|---|
Zeitschrift | Movement Disorders |
Jahrgang | 23 |
Ausgabenummer | 1 |
Seiten (von - bis) | 131-134 |
Seitenumfang | 4 |
ISSN | 0885-3185 |
DOIs | |
Publikationsstatus | Veröffentlicht - 15.01.2008 |